Schiffman Mark, Kjaer Susanne Krüger
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Rm. 7066, Rockville, MD 20852, USA.
J Natl Cancer Inst Monogr. 2003(31):14-9. doi: 10.1093/oxfordjournals.jncimonographs.a003476.
This chapter suggests promising areas of future epidemiologic research on human papillomavirus (HPV) and anogenital cancer, organized around our understanding of cervical carcinogenesis. The major steps in cervical carcinogenesis include HPV infection, HPV persistence over a certain period of time, progression to precancer, and invasion. Backward steps include clearance of HPV infection and regression of precancer. Additional studies of incident HPV infections among virgins initiating sexual activity could clarify the earliest aspects of transmission and immune response. Research on older women and their male partners should focus on understanding the determinants of varying age-specific HPV prevalence curves and underlying dynamics of viral persistence, clearance, and latency. It will be particularly important for epidemiologists to define HPV persistence rigorously in order to guide clinical management and vaccine trials. Intensive longitudinal studies that collect visual, microscopic (cytologic and histologic), and molecular data will be needed to understand the fate of individual HPV infections and to clarify whether multiple, concurrent infections act independently on the cervix. Case-control designs will be useful mainly in searching for new biomarkers of risk of progression among HPV-infected women that could then be validated prospectively. Prospective confirmation is also needed for the etiologic cofactors established by case-control studies of invasive cervical cancer. Much of the knowledge about cervical cancer might apply to anal neoplasia. Epidemiologic studies of other genital tumors such as penile neoplasia are still needed, but multicentric groups must place great emphasis on measurement technology, given the difficulty in obtaining reliable comprehensive measurements.
本章围绕我们对宫颈癌发生机制的理解,提出了未来关于人乳头瘤病毒(HPV)与肛门生殖器癌的流行病学研究的潜在领域。宫颈癌发生的主要步骤包括HPV感染、HPV在一定时期内持续存在、发展为癌前病变以及侵袭。逆向步骤包括HPV感染的清除和癌前病变的消退。对开始性行为的处女中HPV新感染情况的进一步研究,可能会阐明传播和免疫反应的最初方面。对老年女性及其男性伴侣的研究应侧重于了解不同年龄组HPV流行率曲线的决定因素以及病毒持续存在、清除和潜伏的潜在动态。对于流行病学家来说,严格定义HPV持续存在以指导临床管理和疫苗试验尤为重要。需要开展密集的纵向研究,收集视觉、显微镜(细胞学和组织学)及分子数据,以了解个体HPV感染的转归,并阐明多重并发感染是否独立作用于宫颈。病例对照设计主要有助于寻找HPV感染女性中疾病进展风险的新生物标志物,随后可进行前瞻性验证。对于通过浸润性宫颈癌病例对照研究确定的病因协同因素,也需要进行前瞻性确认。许多关于宫颈癌的知识可能适用于肛门肿瘤。仍需要对阴茎肿瘤等其他生殖器肿瘤进行流行病学研究,但鉴于获得可靠的全面测量存在困难,多中心研究团队必须高度重视测量技术。